Browsing Tag
BSE
144 posts
NTPC just hit record capacity additions, signed a nuclear deal with France and still trades at a discount. Worth watching?
NTPC (NSE: NTPC) hit record FY26 capacity additions and signed an EDF nuclear MoU. With ₹380 CMP and analyst targets to ₹440, here is what retail investors need to know.
Wipro (WIT) secures eight-year, $1bn Olam contract and pays $375m for agribusiness IT unit Mindsprint
Wipro secures an $1bn, eight-year Olam Group transformation deal and acquires Mindsprint for $375m. What it means for WIT stock, competitors, and agribusiness IT. Read more.
Cipla Limited (NSE: CIPLA) secures FDA approval for generic nintedanib capsules, entering a $3.8bn U.S. pulmonary fibrosis market
Cipla wins FDA approval for generic nintedanib capsules for IPF, targeting Boehringer Ingelheim's $3.76B Ofev market. Here's what the launch means for investors. Read more.
Granules India (NSE: GRANULES) exits FDA audit with four observations as regulatory scrutiny intensifies
Granules India's Chantilly facility exits a routine US FDA cGMP audit with four procedural Form 483 observations and no data integrity findings. Read what it means for the GRANULES growth outlook.
K.P. Energy (KPEL) signs IPL deal with Delhi Capitals as stock trades 50% below 52-week high
KP Group's three listed companies join Delhi Capitals as IPL associate sponsors for 2026-2028. What does the strategy mean for KPEL and KPIGREEN? Read more.
Orchid Pharma company profile: business model, financials, and growth outlook (2026 Edition)
Orchid Pharma Limited company profile: cephalosporin API leader, FY2025 revenue Rs. 921.93 Cr, Jammu PLI expansion, novel antibiotic pipeline, and 2026-27 growth outlook.
Dev Information Technology (NSE: DEVIT) to offload ByteSIGNER and Talligence as XDuce partnership reshapes strategic direction
Dev Information Technology transfers ByteSIGNER and Talligence to an associate for Rs 11.90 crore as XDuce's 24% stake signals a bold services-only pivot. Read the full analysis.
PhysicsWallah (NSE: PWL) kicks off FY27 academic cycle with Rs 205cr Vishwas Diwas collections, posting 36% year-on-year growth
PhysicsWallah reports Rs 205 crore Vishwas Diwas collections, 36% YoY growth, 439K enrollments. What it means for PWL stock and India edtech. Read more.
Alembic Pharmaceuticals (APLLTD) wins FDA final approval for Paroxetine Extended-Release Tablets
Alembic Pharmaceuticals (APLLTD) wins USFDA final approval for Paroxetine ER 12.5 mg tablets. Read what it means for the US generic pipeline and investor outlook.
Ola Electric’s #EndICEAge campaign slashes entry price to Rs 49,999 to reclaim lost ground in India’s electric two-wheeler market
Ola Electric slashes prices to Rs 49,999 and launches buyback and service guarantees. Is the #EndICEAge campaign enough to reverse India's most dramatic EV market share collapse? Read more.